These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Quantitative and Mechanistic Assessment of Model Lipophilic Drugs in Micellar Solutions in the Transport Kinetics Across MDR1-MDCK Cell Monolayers. Ho NFH; Nielsen J; Peterson M; Burton PS J Pharm Sci; 2016 Feb; 105(2):904-914. PubMed ID: 26869435 [TBL] [Abstract][Full Text] [Related]
44. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa? Tang F; Horie K; Borchardt RT Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945 [TBL] [Abstract][Full Text] [Related]
45. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT). Guo A; Marinaro W; Hu P; Sinko PJ Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101 [TBL] [Abstract][Full Text] [Related]
46. Cytotoxic 1,5-diaryl-3-oxo-1,5-pentadienes: an assessment and comparison of membrane permeability using Caco-2 and MDCK monolayers. Singh RS; Michel D; Das U; Dimmock JR; Alcorn J Bioorg Med Chem Lett; 2014 Nov; 24(22):5199-202. PubMed ID: 25442312 [TBL] [Abstract][Full Text] [Related]
47. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. Wu X; Whitfield LR; Stewart BH Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037 [TBL] [Abstract][Full Text] [Related]
48. Transport of levovirin prodrugs in the human intestinal Caco-2 cell line. Li F; Hong L; Mau CI; Chan R; Hendricks T; Dvorak C; Yee C; Harris J; Alfredson T J Pharm Sci; 2006 Jun; 95(6):1318-25. PubMed ID: 16634069 [TBL] [Abstract][Full Text] [Related]
49. Efflux properties of basolateral peptide transporter in human intestinal cell line Caco-2. Irie M; Terada T; Okuda M; Inui K Pflugers Arch; 2004 Nov; 449(2):186-94. PubMed ID: 15340850 [TBL] [Abstract][Full Text] [Related]
50. Drug-permeability and transporter assays in Caco-2 and MDCK cell lines. Volpe DA Future Med Chem; 2011 Dec; 3(16):2063-77. PubMed ID: 22098353 [TBL] [Abstract][Full Text] [Related]
51. Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers. Soldner A; Benet LZ; Mutschler E; Christians U Br J Pharmacol; 2000 Mar; 129(6):1235-43. PubMed ID: 10725273 [TBL] [Abstract][Full Text] [Related]
52. A comprehensive study demonstrating that p-glycoprotein function is directly affected by changes in pH: implications for intestinal pH and effects on drug absorption. Mitra P; Audus K; Williams G; Yazdanian M; Galinis D J Pharm Sci; 2011 Oct; 100(10):4258-68. PubMed ID: 21538355 [TBL] [Abstract][Full Text] [Related]
53. Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers. Sudoh M; Pauletti GM; Yao W; Moser W; Yokoyama A; Pasternak A; Sprengeler PA; Smith AB; Hirschmann R; Borchardt RT Pharm Res; 1998 May; 15(5):719-25. PubMed ID: 9619780 [TBL] [Abstract][Full Text] [Related]
54. Models to predict unbound intracellular drug concentrations in the presence of transporters. Korzekwa KR; Nagar S; Tucker J; Weiskircher EA; Bhoopathy S; Hidalgo IJ Drug Metab Dispos; 2012 May; 40(5):865-76. PubMed ID: 22279052 [TBL] [Abstract][Full Text] [Related]
55. Transport of the phosphonodipeptide alafosfalin by the H+/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells. Neumann J; Bruch M; Gebauer S; Brandsch M Eur J Biochem; 2004 May; 271(10):2012-7. PubMed ID: 15128310 [TBL] [Abstract][Full Text] [Related]
56. Absorption of folate by Caco-2 cells is not affected by high glucose concentration. Martel F; Gonçalves P; Azevedo I Eur J Pharmacol; 2006 Dec; 551(1-3):19-26. PubMed ID: 17034785 [TBL] [Abstract][Full Text] [Related]
58. Studies on intestinal absorption of sulpiride (2): transepithelial transport of sulpiride across the human intestinal cell line Caco-2. Watanabe K; Sawano T; Endo T; Sakata M; Sato J Biol Pharm Bull; 2002 Oct; 25(10):1345-50. PubMed ID: 12392092 [TBL] [Abstract][Full Text] [Related]
59. Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na+/H+ exchange activity. Kennedy DJ; Leibach FH; Ganapathy V; Thwaites DT Pflugers Arch; 2002 Oct; 445(1):139-46. PubMed ID: 12397398 [TBL] [Abstract][Full Text] [Related]
60. Characterization of dexloxiglumide in vitro biopharmaceutical properties and active transport. Tolle-Sander S; Grill A; Joshi H; Kapil R; Persiani S; Polli JE J Pharm Sci; 2003 Oct; 92(10):1968-80. PubMed ID: 14502537 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]